Note 12 - Revenue

9 Months Ended

Sep. 30, 2019

Notes to Financial Statements

Revenue from Contract with Customer [Text Block]

1 2 . Revenue

We currently operate as

one

reportable operating segment focusing on biopreservation tools.

The following table disaggregates revenue by market segment and distributors:

	Three Month Period Ended				Nine Month Period Ended
	September 30,				September 30,
(In thousands)	2019		2018		2019		2018
Net revenue:
Regenerative medicine	$	3,421	$	2,876	$	9,567	$	7,965
Distributors		2,613		1,887		7,943		4,621
Drug discovery		225		276		711		916
BioBanking		345		255		854		784
Total	$	6,604	$	5,293	$	19,075	$	14,286

 The following table disaggregates revenue by product category:

	Three Month Period Ended				Nine Month Period Ended
	September 30,				September 30,
(In thousands)	2019		2018		2019		2018
Net revenue:
Media	$	6,069	$	5,293	$	18,165	$	14,286
Automated thawing products		324		—		699		—
Cold chain shipping		211		—		211		—
Total	$	6,604	$	5,293	$	19,075	$	14,286